title: The role of EGFR monoclonal antibodies (MoABs) cetuximab/panitumab, and BRAF inhibitors in BRAF mutated colorectal cancer.
authors: Colorectal surgery department, The Second Affiliated Hospital of Harbin Medical University, Harbin, China; ; Colorectal Cancer Institute of Harbin Medical University, Harbin, China.
authors: Shan
authors: S
authors: Muhammad
authors: Zheng
authors: Z
authors: Jiang
authors: Zheng
authors: Z
authors: Liu
authors: Kavanjit
authors: K
authors: Kaur
authors: Xishan
authors: X
authors: Wang